Skip to main content

Table 2 Baseline characteristic of the patients in the FAS

From: The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trial

  Placebo Dexamethasone Total
N = 19 N = 19 N = 38
Gender
 male 10 (52.6%) 11 (57.9%) 21 (55.3%)
 female 9 (47.4%) 8 (42.1%) 17 (44.7%)
Age
 Mean +/− SD 58.6 +/− 15.0 61.6 +/−  12.1 60.1 +/−  13.6
Focal neurological signs
 yes 12 (63.2%) 15 (78.9%) 27 (71.1%)
Seizures within last 5 days
 yes 11 (57.9) 11 (57.9%) 22 (57.9%)
Result of PCR
 positive 19 (100.0%) 19 (100.0%) 38 (100.0%)